Heat Biologics’ Pelican Subsidiary Provides Update on its Novel PTX-35 T-Cell Costimulator Oct 4, 2018
Heat Biologics to Present at the 20th Annual Rodman & Renshaw Global Investment Conference in New York City Aug 29, 2018
Heat Biologics Announces Upcoming Milestones Following Positive Interim Phase 2 Results for HS-110 Apr 18, 2018
Heat Biologics Reports Positive Data to Further Support the Mechanism of Action for its Proprietary T-Cell Activation Platform Mar 26, 2018